DUBLIN, Nov. 23, 2023 /PRNewswire/ — The “India Television Market Competition Forecast & Opportunities, 2028” report has been added to ResearchAndMarkets.com’s offering. The Indian television market is currently witnessing robust demand and is poised for rapid expansion to 2028 This growth is primarily attributed to the increasing popularity of large-screen televisions and smart TVs equipped with… Continue reading India Television Markets Competition Forecast & Opportunities, 2028: OTT Platform Popularity and Increased Demand for Smart Televisions Drives Market Expansion
Category: Newswire
Biosimilar von EirGenix zur Brustkrebs-Therapie erhält Marktzulassung von der Europäischen Kommission
TAIPEH, 24. November 2023 /PRNewswire/ — EirGenix Inc. (6589. TT) gab heute bekannt, dass sein Trastuzumab-Biosimilar (EG12014), das sein Geschäftspartner Sandoz zu vermarkten beabsichtigt (150 mg, zur intravenösen Anwendung), eine Marktzulassung von der Europäischen Kommission (EK) erhalten hat. Die Marktzulassung in der EU gilt für die Behandlung von HER2-positivem Brustkrebs und metastasierendem Magenkrebs, d. h.… Continue reading Biosimilar von EirGenix zur Brustkrebs-Therapie erhält Marktzulassung von der Europäischen Kommission
Broncus has announced the acquisition of the entire interest in Hangzhou Jingliang
HANGZHOU, China, Nov. 23, 2023 /PRNewswire/ — Broncus(2216.HK) is pleased to announce that, on November 23 2023 Broncus Hangzhou (a whollyowned subsidiary of Broncus, as Transferee) has entered into the Equity Transfer Agreement with the shareholders of the Hangzhou Jingliang, to acquire 100% equity interest in it. Broncus is a pioneering medical device company in the… Continue reading Broncus has announced the acquisition of the entire interest in Hangzhou Jingliang
Le biosimilaire d’EirGenix contre le cancer du sein reçoit l’autorisation de mise sur le marché de la CE
TAIPEI, 24 novembre 2023 /PRNewswire/ — EirGenix Inc. (6589. TT) a annoncé aujourd’hui que son médicament biosimilaire du trastuzumab (EG12014) que son partenaire commercial Sandoz prévoit de commercialiser (150 mg en utilisation intraveineuse) avait reçu une autorisation de mise sur le marché de la part de la Commission européenne (CE). L’autorisation de mise sur le marché… Continue reading Le biosimilaire d’EirGenix contre le cancer du sein reçoit l’autorisation de mise sur le marché de la CE
El biosimilar de cáncer de mama de EirGenix recibe la autorización de comercialización de la CE
TAIPEI, 24 de noviembre de 2023 /PRNewswire/ — EirGenix Inc. (6589. TT) anunció hoy que su medicamento biosimilar de trastuzumab (EG12014), que su socio comercial Sandoz planea comercializar (150 mg, para uso intravenoso), había recibido una autorización de comercialización de la Comisión Europea (CE). La autorización de comercialización en la UE cubrirá el tratamiento del… Continue reading El biosimilar de cáncer de mama de EirGenix recibe la autorización de comercialización de la CE
China Prepaid Card and Digital Wallet Business Databook 2023 – Market Size and Forecasts, Consumer Attitude & Behaviour, Retail Spend 2018-2027
DUBLIN, Nov. 23, 2023 /PRNewswire/ — The “China Prepaid Card and Digital Wallet Business and Investment Opportunities Databook – Market Size and Forecast, Consumer Attitude & Behaviour, Retail Spend – Q2 2023 Update” report has been added to ResearchAndMarkets.com’s offering. The prepaid card market (value terms) in China increased at a CAGR of 9.3% during 2018-2022.… Continue reading China Prepaid Card and Digital Wallet Business Databook 2023 – Market Size and Forecasts, Consumer Attitude & Behaviour, Retail Spend 2018-2027
Solar technology promotes global energy equity, says LONGi founder & president Li Zhenguo at APEC CEO Summit
SAN FRANCISCO, Nov. 23, 2023 /PRNewswire/ — The 2023 APEC CEO Summit was held on November 15 at the Moscone Center West in San Francisco, California. Leaders including Li Zhenguo, founder & president of LONGi Green Energy Technology Co., Ltd. (LONGi), the world leading solar technology company headquartered in Xi’an, China, and Dara Khosrowshahi, CEO of… Continue reading Solar technology promotes global energy equity, says LONGi founder & president Li Zhenguo at APEC CEO Summit
United Kingdom Loan Market Competition, Forecast & Opportunities, 2028 – Rising Consolidated Debts and Increased Digitalization Boosts Growth
DUBLIN, Nov. 23, 2023 /PRNewswire/ — The “United Kingdom Loan Market Competition Forecast & Opportunities, 2028” report has been added to ResearchAndMarkets.com’s offering. The United Kingdom loan market is anticipated to project robust growth in the forecast period because of increasing digitalization, increasing demand from automation in the loan process, and increasing marketing strategies. A loan… Continue reading United Kingdom Loan Market Competition, Forecast & Opportunities, 2028 – Rising Consolidated Debts and Increased Digitalization Boosts Growth
China’s First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351
ROCKVILLE, Md. and SUZHOU, China, Nov. 23, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the New Drug Application (NDA) for IBI351 (KRAS G12C inhibitor) has been accepted by the Center… Continue reading China’s First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351
RFID Technology Revolutionizes Global Healthcare Market, Offering Opportunities in Asset, Patient, and Pharmaceutical Tracking
DUBLIN, Nov. 23, 2023 /PRNewswire/ — The “RFID in Healthcare Market: Trends, Opportunities and Competitive Analysis (2023-2028)” report has been added to ResearchAndMarkets.com’s offering. This comprehensive report delves into the RFID (Radio-Frequency Identification) landscape within the global healthcare market, providing valuable insights into market trends, growth opportunities, and competitive dynamics. The utilization of RFID technology in the… Continue reading RFID Technology Revolutionizes Global Healthcare Market, Offering Opportunities in Asset, Patient, and Pharmaceutical Tracking